中国医药导报
中國醫藥導報
중국의약도보
CHINA MEDICAL HERALD
2014年
23期
64-66,70
,共4页
蒋岳达%吴彩芬%娄昭君%管敏昌%金小红
蔣嶽達%吳綵芬%婁昭君%管敏昌%金小紅
장악체%오채분%루소군%관민창%금소홍
连花清瘟胶囊%利巴韦林气雾剂%急性上呼吸道感染%疗效
連花清瘟膠囊%利巴韋林氣霧劑%急性上呼吸道感染%療效
련화청온효낭%리파위림기무제%급성상호흡도감염%료효
Lianhua Qingwen Capsule%Ribavirin Aerosol%Acute upper respiratory tract infection%Therapeutic effi-cacy
目的:探讨连花清瘟胶囊联合利巴韦林气雾剂治疗急性上呼吸道感染的效果。方法选择临海市桃渚中心卫生院内科门诊确诊为急性上呼吸道感染患者364例,将其随机分为治疗组和对照组,各182例。对照组给予利巴韦林泡腾颗粒口服,0.15 g/次,3次/d,连用3 d;治疗组采用连花清瘟胶囊,4粒/次,3次/d;利巴韦林气雾剂,首次使用1h内喷4次,2~3揿/次,以后每隔1h喷1次,2~3揿/次,2d以后4次/d,2~3揿/次,连用3d。两组5d后评价疗效。结果治疗组显效141例,有效34例,无效7例,有效率为96.2%;对照组显效89例,有效69例,无效24例,有效率为86.8%,两组治疗效果比较,差异有高度统计学意义(P<0.01)。治疗组热退时间为(2.41±1.15)d,咳嗽消失时间为(3.13±1.39)d,流涕消失时间为(2.29±1.34)d,咽部充血消失时间为(3.58±1.37)d;对照组热退时间为(3.16±1.07)d,咳嗽消失时间为(4.25±1.32)d,流涕消失时间为(3.46±1.18)d,咽部充血消失时间为(4.36±1.26)d,两组临床症状比较差异有高度统计学意义(P<0.01)。结论连花清瘟胶囊联合利巴韦林气雾剂治疗急性上呼吸道感染效果确切,值得推广应用。
目的:探討連花清瘟膠囊聯閤利巴韋林氣霧劑治療急性上呼吸道感染的效果。方法選擇臨海市桃渚中心衛生院內科門診確診為急性上呼吸道感染患者364例,將其隨機分為治療組和對照組,各182例。對照組給予利巴韋林泡騰顆粒口服,0.15 g/次,3次/d,連用3 d;治療組採用連花清瘟膠囊,4粒/次,3次/d;利巴韋林氣霧劑,首次使用1h內噴4次,2~3撳/次,以後每隔1h噴1次,2~3撳/次,2d以後4次/d,2~3撳/次,連用3d。兩組5d後評價療效。結果治療組顯效141例,有效34例,無效7例,有效率為96.2%;對照組顯效89例,有效69例,無效24例,有效率為86.8%,兩組治療效果比較,差異有高度統計學意義(P<0.01)。治療組熱退時間為(2.41±1.15)d,咳嗽消失時間為(3.13±1.39)d,流涕消失時間為(2.29±1.34)d,嚥部充血消失時間為(3.58±1.37)d;對照組熱退時間為(3.16±1.07)d,咳嗽消失時間為(4.25±1.32)d,流涕消失時間為(3.46±1.18)d,嚥部充血消失時間為(4.36±1.26)d,兩組臨床癥狀比較差異有高度統計學意義(P<0.01)。結論連花清瘟膠囊聯閤利巴韋林氣霧劑治療急性上呼吸道感染效果確切,值得推廣應用。
목적:탐토련화청온효낭연합리파위림기무제치료급성상호흡도감염적효과。방법선택림해시도저중심위생원내과문진학진위급성상호흡도감염환자364례,장기수궤분위치료조화대조조,각182례。대조조급여리파위림포등과립구복,0.15 g/차,3차/d,련용3 d;치료조채용련화청온효낭,4립/차,3차/d;리파위림기무제,수차사용1h내분4차,2~3흠/차,이후매격1h분1차,2~3흠/차,2d이후4차/d,2~3흠/차,련용3d。량조5d후평개료효。결과치료조현효141례,유효34례,무효7례,유효솔위96.2%;대조조현효89례,유효69례,무효24례,유효솔위86.8%,량조치료효과비교,차이유고도통계학의의(P<0.01)。치료조열퇴시간위(2.41±1.15)d,해수소실시간위(3.13±1.39)d,류체소실시간위(2.29±1.34)d,인부충혈소실시간위(3.58±1.37)d;대조조열퇴시간위(3.16±1.07)d,해수소실시간위(4.25±1.32)d,류체소실시간위(3.46±1.18)d,인부충혈소실시간위(4.36±1.26)d,량조림상증상비교차이유고도통계학의의(P<0.01)。결론련화청온효낭연합리파위림기무제치료급성상호흡도감염효과학절,치득추엄응용。
Objective To explore the therapeutic efficacy of Lianhua Qingwen Capsule combined with Ribavirin Aerosol in patients with acute upper respiratory tract infection. Methods 364 patients with acute upper respiratory tract infection in the outpatient department of Internal Medicine in Taozhu Central Hospital of Linhai City were randomly di-vided into control group (n=182) and treatment group (n=182). Patients in control group were taken Ribavirin Effer-vescent Granules, three times daily on 3 successive days. Patients in treatment group were taken Lianhua Qingwen Capsule by four tablet three times daily and Ribavirin Aerosol sprayed four times an hour and 2-3 presses per time, then sprayed once every hour and 2-3 presses per time, then two days later, prayed four times a day and 2-3 presses per time, 3 successive days, and therapeutic effects in both groups were evaluated after 5 days. Results In the treat-ment group, 141 cases were remarkably effective, 34 cases were effective, 7 cases were ineffective and the effective rate was 96.2%; while in the control group, 89 cases were remarkably effective, 69 cases were effective and 24 cases were ineffective, the effective rate was 86.8%, there was a significant difference in therapeutic effect between the two groups (P<0.01). In the treatment group, the fever annealing time was (2.41±1.15) days, cough disappearance time was (3.13±1.39) days, runny nose disappearance time was (2.29±1.34) days, and pharyngeal congestion disappearance time was (3.58±1.37) days, while in the control group, the fever annealing time was (3.16±1.07) days, cough disappearance time was (4.25±1.32) days, runny nose disappearance time was (3.46±1.18) days, and pharyngeal congestion disappear-ance time was (4.36±1.26) days, there were significant differences between the two groups (P< 0.01). Conclusion It has a definite therapeutic effect of Lianhua Qingwen Capsule combined with Ribavirin Aerosol in patients with acute upper respiratory tract infection, and it deserves popularization and application.